SUNDAY, April 13 (HealthDay News) -- New research suggests that
muscle weakness in a child with autism may point to an underlying
genetic defect that's causing mitochondrial disease, which means
the muscles don't get the energy they need.
Conversely, it's possible that the mitochondrial disease may
also play a role in the development of autism, perhaps by
preventing the brain from getting the energy it needs to perform
properly, the researchers noted.
"In large studies of kids with autism, about 20 percent have
markers of mitochondrial disease in the blood," explained Dr. John
Shoffner, an associate professor of biology at Georgia State
University and president of Medical Neurogenetics.
Shoffner recently completely a retrospective analysis of 37
children with autism spectrum disorders and found that 65 percent
of these children -- children who had been referred to him because
their doctors suspected additional problems -- had mitochondrial
defects.
He was expected to present the findings April 13 at the American
Academy of Neurology's annual meeting, in Chicago.
Mitochondria are found in every cell of the body, with the
exception of red blood cells, according to the United Mitochondrial
Disease Foundation (UMDF). Mitochondria are vital to survival,
because they make oxygen available to cells and metabolize food
into energy for cells to thrive. Defects in mitochondria can lead
to cell injury, or even cell death, according to UMDF.
Symptoms of mitochondrial disease depend on which body system is
affected but may include muscle weakness, loss of muscle control,
poor growth, heart disease, diabetes, developmental delays, an
increased risk of infection and more.
Shoffner said that the mitochondrial energy production system is
the only one in the body that requires two genomes to work -- genes
inherited from both the mother and the father, and genes
exclusively from the mother. "To make this system work, it requires
a lot of genes. Hence the opportunity for lots of problems," said
Shoffner, who added that there are several hundred known
mitochondrial disorders.
Twenty-four (65 percent) of the children included in this study
had genetic defects in their skeletal muscles. However, that
doesn't mean that 65 percent of children with autism likely have
mitochondrial disease. This was a select population of kids with
autism, ones that had specifically been referred, because their
doctors suspected a problem.
But, Shoffner pointed out that as many as one in five youngsters
with autism spectrum disorders have shown signs of mitochondrial
disease.
"If you're talking about 20 percent of kids with autism, that's
a whole lot of children, and may represent an important segment of
the autism spectrum disorder population. And we may be getting a
foothold into the underlying cause of autism spectrum disorders,"
he said, adding, "This is a really important step forward that lets
us put effort into understanding the mechanisms of disease."
"This study is a call to action. We need to know what is the
real prevalence of mitochondrial conditions in children with
autism," said Geraldine Dawson, chief science officer for Autism
Speaks. "The more we can identify these subgroups of kids, the more
we're going to parse apart the many forms of autism. This gives us
clues to etiology."
"If we find that mitochondrial disease is a prevalent condition,
having a better understanding of the kinds of symptoms that
children may show if they have it might be helpful for parents,"
she said.
Shoffner said these findings may also open up new avenues of
research into potentially more effective treatments for the
future.
More information
To learn more about autism, visit
Autism Speaks.